Copyright
©The Author(s) 2018.
World J Gastrointest Oncol. Aug 15, 2018; 10(8): 211-220
Published online Aug 15, 2018. doi: 10.4251/wjgo.v10.i8.211
Published online Aug 15, 2018. doi: 10.4251/wjgo.v10.i8.211
N | Median OS (mo) | 95%CI | N | Median OS (mo) | 95%CI | |
Resection | No resection or palliative surgery | |||||
Positive studies | ||||||
Fujii et al[46] | 7 | 20 | NA | |||
Kurosaki et al[47] | 13 | 28-60 | 9 | 6-12 | ||
Niguma et al[50] | 10 | 17.2 | 12 | 4.4 | ||
de Jong et al[48] | 8 | 17-19 | 7 | 7 | < 0.01 | |
Adam et al[13] | 15 | 38 | NA | |||
Negative studies | ||||||
Gleisner et al[37] | 5 | 9.9 | 6 | 0.43 | ||
Wakai et al[45] | 3 | 9 | NA | |||
Bresadola et al[49] | 7 | 15 | NA |
- Citation: Lee RC, Kanhere H, Trochsler M, Broadbridge V, Maddern G, Price TJ. Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases? World J Gastrointest Oncol 2018; 10(8): 211-220
- URL: https://www.wjgnet.com/1948-5204/full/v10/i8/211.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v10.i8.211